Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India · Delayed Price · Currency is INR 20.18
+0.31 (1.56%)
At close: Jun 19, 2026
BOM:531015 Market Cap
BOM:531015 has a market cap or net worth of 233.74 million as of June 18, 2026. Its market cap has increased by 63.43% in one year.
Market Cap
233.74M
Enterprise Value
224.82M
Revenue
80.25M
Ranking
n/a
PE Ratio
96.10
Stock Price
20.18
Market Cap Chart
Since April 15, 2008, BOM:531015's market cap has increased from 32.40M to 233.74M, an increase of 621.46%. That is a compound annual growth rate of 11.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 233.74M | 78.82% |
| Dec 31, 2025 | 130.71M | 38.30% |
| Dec 31, 2024 | 94.51M | 357.87% |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kimia Biosciences | 1.53B |
| Krebs Biochemicals & Industries | 1.42B |
| Smruthi Organics | 1.35B |
| Tyche Industries | 1.31B |
| Bacil Pharma | 581.87M |
| Vasundhara Rasayans | 540.93M |
| Crestchem | 428.25M |
| Alfavision Overseas (India) | 260.72M |